RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Electrochemical analyzer of biological barcodes

Product
Developers: McMaster's (McMaster University) university
Date of the premiere of the system: October, 2020
Branches: Pharmaceutics, medicine, health care

2020: The announcement of the electrochemical analyzer of biological barcodes for diagnosis of cancer

At the end of October, 2020 the Canadian researchers from McMaster's (McMaster University) University developed a portable device which allows to estimate quickly existence of biomarkers of cancer in blood samples. This device called by the electrochemical analyzer of biological barcodes can be used for measurement of different markers in house conditions.

The group of researchers noted that the analysis of biomarkers is usually expensive and takes a lot of time therefore developed a portable analytical system and showed its efficiency on the example of a well-known biomarker of cancer, specific antigen of a prostate (DOG). To check the level of this biomarker, the user needs to mix a blood drop with a small volume of a reactant, to drip mix on a test strip, and then to insert it into the reader device. The device issues result within several minutes, and it can be connected with the smartphone with the help of a special application which allows to browse results.

The electrochemical analyzer of biological barcodes for the smartphone estimating cancer biomarkers is provided
File:Aquote1.png
It is one more step to really personalized medicine, - the researcher Leyla Soleymani considers. - We leave from the centralized laboratory equipment to new, portable, personal devices. It will make monitoring much more available and will allow patients to carry out it at home, without addressing to specialized agencies for delivery of a blood sample.
File:Aquote2.png

A system includes complexes of DNA antibodies which contact target protein in a sample. The device allows to estimate the unprocessed samples of plasma of the person. Meanwhile as confirmation of the concept it was shown that a system precisely estimates concentration of PSA in plasma of the person with the broad range of values, however this technology can be used also for measurement of other biomarkers specific to oncological diseases.

By October, 2020 McMaster's University attracted investments for commercial project implementation. The size of investments is not specified.[1]

Notes